A carregar...
Measurable residual disease in the treatment of chronic lymphocytic leukemia
Treatment outcomes of chronic lymphocytic leukemia (CLL) have improved since chemoimmunotherapy and novel drugs became available for CLL treatment; therefore, more sensitive methods to evaluate residual CLL cells in patients are required. Measurable residual disease (MRD) has been assessed in severa...
Na minha lista:
| Publicado no: | J Clin Exp Hematop |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Japanese Society for Lymphoreticular Tissue Research
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7810249/ https://ncbi.nlm.nih.gov/pubmed/33148932 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3960/jslrt.20014 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|